Management of Early Melanoma and Atypical Spitz Tumors

Program Description:

Integral components of melanoma management include patient awareness of skin changes, as well as early and accurate identification, institution of treatment interventions, and high levels of expertise among members of the health care team. This webcast and the accompanying Management of Metastatic Melanoma provide clinicians and other health care professionals with the most recent, relevant research, treatment options, clinical data, guidance, and resources to optimize disease detection management, patient care, and overall health outcomes in dealing with melanoma.

INTENDED AUDIENCE:

This program is intended for medical oncologists, surgical oncologists, dermatologists, oncology nurses, and other health care professionals who treat patients with melanoma.

Activity Objectives:

Upon completion of this educational activity, participants should be better able to:

• Compare the advantages and disadvantages of diagnostic and staging tools to improve screening and detection, and to tailor care plans to patients with early melanoma.


• Define and differentiate Spitzoid tumors in different patient presentations to avoid misdiagnosis, mistreatment, and other deleterious patient outcomes.

Credits	Type	Accreditation Statement	Designation Statement
1.00	AMA PRA Category 1 Credit(s)TM	This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Elsevier Office of Continuing Medical Education (EOCME), Massachusetts General Hospital Academy and Reed Medical Education. EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.	EOCME designates this internet-based enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty:

Arthur Sober, M.D.
Medical Director, Medical Dermatology
Massachusetts General Hospital

Professor of Dermatology
Harvard Medical School

Hensin Tsao, M.D., Ph.D.
Director, Melanoma Genetics Program
MGH Cancer Center
Massachusetts General Hospital

Associate Professor of Dermatology
Harvard Medical School

Kenneth Tanabe, M.D.
Chief, Surgical Oncology
Massachusetts General Hospital

Surgeon, Gastrointestinal Cancer Center
Dana-Farber Cancer Institute

Professor, Department of Surgery
Harvard Medical School

Disclosures:

Resolution of Conflict of Interest
The EOCME has implemented a process to resolve conflict of interest for each CME activity. In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, the EOCME has resolved the conflict by external content review.

Faculty and Provider Disclosure
This program was developed by Drs. Arthur Sober, MD, Hensin Tsao, MD, PhD, and Kenneth Tanabe, MD. Dr. Sober has indicated that he receives honoraria as a consultant for Mela Sciences. Dr. Tsao has indicated that he receives honoraria as a consultant for Quest Diagnostics, Scribase, and Metamark. Dr. Tanabe has indicated that he receives honoraria as a consultant for Morningside Technology, LLC, LEK Consulting, and Summer Street Research Partners, and as an editor for UptoDate.

Planning Committee Disclosures
Anan Nathif has no financial relationships to disclose.
Timothy Lynch has no financial relationships to disclose.
Tristan Nelsen, Elsevier Office of CME, has no financial relationships to disclose.
Rob Reina, MS, MBA, Educational Reviewer, has no financial relationships to disclose.

Commercial Supporter Disclosure
Our evidence-based curriculum is supported by educational grants from Bristol-Myers Squibb, ImClone, and Lilly.









Unapproved/Off-Label Use Disclosure
The EOCME requires CME faculty to disclose to the participants:
1. When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analysis, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Instructions:

Method of Participation
In order to claim credit, participants must complete the following:

1. Pre-activity self-assessment questions
2. View the activity
3. Complete the CME Test and Evaluation. Participants must achieve a score 70% on the CME Test.

Participants can complete the pre-activity self-assessment and CME Test and Evaluation by pressing the continue button below. Upon successful completion of the online tests and evaluation form, you can instantly download and print your certificate of credit.

CME Inquiries:

We encourage participation by all individuals. If you have any special needs or inquiries, please contact the EOCME at elseviercme@elsevier.com for assistance.

SYSTEM REQUIREMENTS for this activity:

Hardware/Software Requirements
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled.

Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal Hardware/Software System Configuration:

Flash Player: Adobe Flash Player 10.1+; Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+; Operating System: Windows XP+ or Mac OS X 10.4+; Internet Connection: 1 Mbps or higher

Minimum Requirements:

Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; 800 x 600 screen resolution set for "High Color (16-Bit)"; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera

Macintosh^®:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

A broadband connection of at least 500+ Kbps is required.

SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH^® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.